Vaccines

All vaccines available in New Zealand are licensed for use in this country.

Vaccines on the New Zealand National Immunisation Schedule are free when given as part of the Schedule. Other vaccines are not funded, but are available for purchase through your family doctor.


The 2014 National Immunisation Schedule came into effect on 1 July.
We are in the process of updating the eligibility information for Boostrix®, Gardasil®, HBvaxPro®, Infanrix®-hexa, Infanrix®-IPV, Menactra®, Neisvac-C™, Prevenar 13® and Varilrix®.

Schedule Vaccines

Act-HIB™ is used for primary and booster vaccination of infants and children up to their 5th birthday to protect against disease caused by ...

ADT™ Booster is used for primary and booster vaccination of children 7 years of age and over and adults to protect against tetanus and diphtheria...

Boostrix® is used for booster vaccination of adolescents aged 11 years and pregnant women between 28-38 weeks gestation* to protect against...

Gardasil® is funded for use for primary immunisation of girls from 9 years of age and young women to protect them from four types of human...

HBvaxPRO® is used for primary vaccination of infants, children and adults to protect against the hepatitis B virus. HBvaxPRO® is also given to...

Infanrix®-hexa is used for primary and booster vaccination of infants and children to protect against diphtheria, tetanus, pertussis,...

Infanrix®-IPV is used for primary and booster vaccination of infants and children to protect against diphtheria, tetanus, pertussis and...

The influenza vaccine is given to protect against influenza in children older than six months of age and adults. The World Health Organization...

IPOL is used for primary and booster vaccination of infants, children and adults to protect against infection with Type 1, Type 2 and Type 3...

M-M-R® II is used for primary vaccination and revaccination of children and adults to protect against measles, mumps and rubella.

Menactra® is a meningococcal A,C,Y,W-135 conjugate vaccine used to protect against four groups of Neisseria meningitidis, group A, group C...

NeisVac-C™ is a menincococcal C conjugate vaccine used to protect against Neisseria meningitidis group C only.

The conjugate and...

Pneumovax® 23 is used for vaccination of children 2 years of age and over and adults to protect against disease caused by 23 types of...

Prevenar 13® is used for primary and booster immunisation of infants and children and primary immunisation of adults at increased risk of ...

RotaTeq® is an immunisation given to infants by mouth (orally) to protect them from severe rotavirus infection. RotaTeq® is free on the National...

Synflorix® is used for primary and booster vaccination of infants and children up to their 5th birthday to protect against disease caused by 10...

Varilrix® is used for primary vaccination of infants from nine months of age, children and adults to protect against varicella-zoster infection (...

Other Vaccines

Adacel® is a privately purchased vaccine that protects against tetanus, diphtheria and whooping cough.

Avaxim® is used to prevent infection with the hepatitis A virus.

Engerix®-B is a privately purchased vaccine to protect against hepatitis B for adolescents aged 18 years and over and adults who do not meet the eligibility criteria for funded HBvaxPRO®.

Havrix® is used to prevent infection with the hepatitis A virus.

Mencevax® ACWY is used for vaccination of children two years of age and over and adults to protect against four groups of Neisseria meningitidis, group A, group C, group Y and group W-135...

Meningitec® is a menincococcal C conjugate vaccine used to protect against Neisseria meningitidis group C only.

Menomune® is used for vaccination of children two years of age and over and adults to protect against four groups of Neisseria meningitidis, group A, group C, group Y and group W-135.

Rotarix® is used for primary vaccination of infants to protect from rotavirus infection. The first dose is given between six and 14 weeks of age.

Varivax® is used for primary vaccination of children from 12 months of age and adults to protect against varicella-zoster infection (chickenpox).

Zostavax® is used to prevent the occurrence of herpes zoster (shingles) in adults aged 50 years and older.